Fawwad Qureshi Sells 622 Shares of Trupanion, Inc. (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) CFO Fawwad Qureshi sold 622 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the sale, the chief financial officer now directly owns 9,867 shares of the company’s stock, valued at $519,102.87. This represents a 5.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Trupanion Stock Performance

Shares of TRUP stock opened at $53.50 on Friday. The company has a market capitalization of $2.27 billion, a P/E ratio of -167.19 and a beta of 1.69. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. The company’s 50 day moving average price is $49.73 and its two-hundred day moving average price is $40.06.

Trupanion (NASDAQ:TRUPGet Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.09. The business had revenue of $327.50 million for the quarter, compared to analysts’ expectations of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The firm’s revenue was up 14.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.10) EPS. On average, analysts expect that Trupanion, Inc. will post -0.23 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

TRUP has been the subject of several research reports. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Northland Securities boosted their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus increased their price objective on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research report on Monday, September 23rd. Bank of America lifted their target price on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research note on Friday, September 20th. Finally, Piper Sandler upped their price target on Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $44.67.

Read Our Latest Stock Analysis on Trupanion

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. State Board of Administration of Florida Retirement System increased its position in shares of Trupanion by 12.6% in the first quarter. State Board of Administration of Florida Retirement System now owns 12,726 shares of the financial services provider’s stock valued at $351,000 after acquiring an additional 1,420 shares during the last quarter. Vanguard Group Inc. grew its stake in shares of Trupanion by 0.9% in the first quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock valued at $101,433,000 after buying an additional 32,485 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in Trupanion by 2.0% during the first quarter. CANADA LIFE ASSURANCE Co now owns 43,060 shares of the financial services provider’s stock worth $1,188,000 after buying an additional 830 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in Trupanion by 14.6% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,325 shares of the financial services provider’s stock worth $313,000 after acquiring an additional 1,441 shares in the last quarter. Finally, Bayesian Capital Management LP acquired a new stake in Trupanion in the first quarter valued at $253,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Articles

Insider Buying and Selling by Quarter for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.